Crestline Management’s Bruker BRKR Stock Holding History

Crestline Management’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-16,021	Closed	-$374K	–	136
2017 Q1	$374K	Buy	+16,021	New	+$376K	0.07%	100

Other funds holding BRKR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Crestline Management's BRKR Position: Q2 2017 in Review

Crestline Management sold out of Bruker (BRKR) in Q2 2017, closing a stake of 16,021 shares — an estimated $374K sold.

Crestline Management first reported a position in BRKR in Q1 2017 and held it in 1 quarter. The position peaked at $374K in Q1 2017. 200 funds tracked by Wall St. Rank hold BRKR as of Q2 2017.

Crestline Management reported no remaining Bruker position as of Q2 2017 after selling out during the quarter.
Crestline Management sold 16,021 Bruker shares in Q2 2017, an estimated $374K.
Crestline Management first reported a position in Bruker in Q1 2017 and held it in 1 quarter.
Crestline Management's Bruker position peaked at $374K in Q1 2017.
200 funds tracked by Wall St. Rank held Bruker as of Q2 2017.

Based on Crestline Management's 13F filing for Q2 2017, filed 14 Aug 2017.